These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26408644)

  • 1. Molecular and cellular mechanisms of glucagon-like peptide-1 receptor agonist-mediated attenuation of cardiac fibrosis.
    Gaspari T; Brdar M; Lee HW; Spizzo I; Hu Y; Widdop RE; Simpson RW; Dear AE
    Diab Vasc Dis Res; 2016 Jan; 13(1):56-68. PubMed ID: 26408644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction.
    Withaar C; Meems LMG; Markousis-Mavrogenis G; Boogerd CJ; Silljé HHW; Schouten EM; Dokter MM; Voors AA; Westenbrink BD; Lam CSP; de Boer RA
    Cardiovasc Res; 2021 Jul; 117(9):2108-2124. PubMed ID: 32871009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liraglutide, a Glucagon-like Peptide-1 Receptor Agonist, Attenuates Development of Cardiac Allograft Vasculopathy in a Murine Heart Transplant Model.
    Wang Z; Wang M; Hu X; Li Y; Ma D; Li S; Zhao G; Xie Y; Shu Y; Yang J
    Transplantation; 2019 Mar; 103(3):502-511. PubMed ID: 30211824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liraglutide treatment improves the coronary microcirculation in insulin resistant Zucker obese rats on a high salt diet.
    Sukumaran V; Tsuchimochi H; Sonobe T; Waddingham MT; Shirai M; Pearson JT
    Cardiovasc Diabetol; 2020 Feb; 19(1):24. PubMed ID: 32093680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity.
    Noyan-Ashraf MH; Shikatani EA; Schuiki I; Mukovozov I; Wu J; Li RK; Volchuk A; Robinson LA; Billia F; Drucker DJ; Husain M
    Circulation; 2013 Jan; 127(1):74-85. PubMed ID: 23186644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1/AT 2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart.
    Zhang LH; Pang XF; Bai F; Wang NP; Shah AI; McKallip RJ; Li XW; Wang X; Zhao ZQ
    Cardiovasc Drugs Ther; 2015 Jun; 29(3):243-55. PubMed ID: 25994830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension.
    Helmstädter J; Frenis K; Filippou K; Grill A; Dib M; Kalinovic S; Pawelke F; Kus K; Kröller-Schön S; Oelze M; Chlopicki S; Schuppan D; Wenzel P; Ruf W; Drucker DJ; Münzel T; Daiber A; Steven S
    Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):145-158. PubMed ID: 31747801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of protein kinase B2 preserves cardiac function by blocking interleukin-6-mediated injury and restores blood pressure during angiotensin II/high-salt-diet-induced hypertension.
    Yang S; Chen D; Chen F; Zhao X; Zhang Y; Li Z; Jin L; Xu Y; Sanchis D; Ye J
    J Hypertens; 2018 Apr; 36(4):834-846. PubMed ID: 29120957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eplerenone attenuates myocardial fibrosis in the angiotensin II-induced hypertensive mouse: involvement of tenascin-C induced by aldosterone-mediated inflammation.
    Nishioka T; Suzuki M; Onishi K; Takakura N; Inada H; Yoshida T; Hiroe M; Imanaka-Yoshida K
    J Cardiovasc Pharmacol; 2007 May; 49(5):261-8. PubMed ID: 17513943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon Like Peptide-1 Receptor Agonists Alter Pancreatic and Hepatic Histology and Regulation of Endoplasmic Reticulum Stress in High-fat Diet Mouse Model.
    Fang T; Huang S; Chen Y; Chen Z; Chen J; Hu W
    Exp Clin Endocrinol Diabetes; 2021 Sep; 129(9):625-633. PubMed ID: 32961563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat-Fed Diabetic Mice.
    Mulvihill EE; Varin EM; Ussher JR; Campbell JE; Bang KW; Abdullah T; Baggio LL; Drucker DJ
    Diabetes; 2016 Mar; 65(3):742-54. PubMed ID: 26672095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
    Weisberg AD; Albornoz F; Griffin JP; Crandall DL; Elokdah H; Fogo AB; Vaughan DE; Brown NJ
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats.
    Inoue T; Inoguchi T; Sonoda N; Hendarto H; Makimura H; Sasaki S; Yokomizo H; Fujimura Y; Miura D; Takayanagi R
    Atherosclerosis; 2015 May; 240(1):250-9. PubMed ID: 25818251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
    Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
    Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL2-dependent macrophage recruitment is critical for mineralocorticoid receptor-mediated cardiac fibrosis, inflammation, and blood pressure responses in male mice.
    Shen JZ; Morgan J; Tesch GH; Fuller PJ; Young MJ
    Endocrinology; 2014 Mar; 155(3):1057-66. PubMed ID: 24428529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liraglutide Attenuates Myocardial Fibrosis via Inhibition of AT1R-Mediated ROS Production in Hypertensive Mice.
    Chen P; Yang F; Wang W; Li X; Liu D; Zhang Y; Yin G; Lv F; Guo Z; Mehta JL; Wang X
    J Cardiovasc Pharmacol Ther; 2021 Mar; 26(2):179-188. PubMed ID: 32686479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats.
    Rehman A; Leibowitz A; Yamamoto N; Rautureau Y; Paradis P; Schiffrin EL
    Hypertension; 2012 Feb; 59(2):291-9. PubMed ID: 22184324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5TNF-α and IL-1β neutralization ameliorates angiotensin II-induced cardiac damage in male mice.
    Wang Y; Li Y; Wu Y; Jia L; Wang J; Xie B; Hui M; Du J
    Endocrinology; 2014 Jul; 155(7):2677-87. PubMed ID: 24877626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in cell-type-specific responses to angiotensin II explain cardiac remodeling differences in C57BL/6 mouse substrains.
    Cardin S; Scott-Boyer MP; Praktiknjo S; Jeidane S; Picard S; Reudelhuber TL; Deschepper CF
    Hypertension; 2014 Nov; 64(5):1040-6. PubMed ID: 25069667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of linagliptin and liraglutide on glucose- and angiotensin II-induced collagen formation and cytoskeleton degradation in cardiac fibroblasts in vitro.
    Wang XW; Zhang FX; Yang F; Ding ZF; Agarwal N; Guo ZK; Mehta JL
    Acta Pharmacol Sin; 2016 Sep; 37(10):1349-1358. PubMed ID: 27498780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.